BioNexus Gene Lab Corp cotiza a 1.32 USD y tiene una capitalización bursátil de $4M. En los últimos 12 meses ha facturado $3M con un margen de flujo de caja libre del -25.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Materiales básicos
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three s…
| Métrica | BGLC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 14.6% | 23.8% | -9.2% |
| Operating Margin | -39.9% | 0.5% | -40.4% |
| Net Margin | -40.2% | 1.0% | -41.2% |
| FCF Margin | -25.3% | 2.0% | -27.3% |
| ROE | -34.6% | -1.9% | -32.8% |
| ROA | -32.3% | -3.6% | -28.6% |
| Current Ratio | 10.46 | 2.07 | +8.39 |
| Debt / Equity | — | 0.50 | — |